Moreover, S1P enhances insulin-like growth factor (IGF2) production and activity; this alteration was linked to an increased susceptibility of many carcinomas through IGF2-mediated promoting insulin growth factor 1 receptor (IGF1R) or hybrid receptors that may promote tumorigenesis. This evidence concerns the gene IGF2 and carcinoma.